Past Research students

N/A

Ongoing research projects

1. Determination of resistance frequency and intensity among Field Populations of malaria vectors to public health insecticides in use in endemic States of India.
2. Nodal Officer: M.Sc. Public Health Entomology (2022 - )

Current research collaborators

N/A

Past research collaborators

N/A

Research in news

N/A

Award/Recognition/Honours

1. Awarded Dr. D.S. Kothari Post-doctoral Fellowship by University grants commission (UGC) for 2015-2017.
2. Award of Travel grant from Indian council of medical research (ICMR), Department of Science & Technology (DST) and Department of Biotechnology (DBT) India for poster presentation in USA in 2011.
3. Awarded Junior research fellowship (2007-2009) and Senior research fellowship (2009-2012 by Indian council of medical research (ICMR).
4. Awarded the National Eligibility Test- Lectureship (NET-LS) conducted by the Council of Scientific and Industrial Research & University Grants commission, Government of India (CSIR-NET) in 2006.
5. Awarded Merit cum mean (MCM) scholarship by JNU

Workshop/Conference Organized

1. Biosparks 2009: The 7th Annual research festival of School of life Sciences, JNU, on 6-7 march 2009.

Academic contributions

Supervisor of Ph. D. thesis: Nil

Masters dissertation: 1

Papers published: 11

Research Grants

Nil

Publications

• Chandel N, Maile A, Shrivastava S, Verma AK, Thakur V. Establishment and perturbation of human gut microbiome: common trends and variations between Indian and global populations , Gut Microbiome, 2024: 1-48. Impact Factor: NA
Verma K, Chaturvedi R, Lahariya AK, Verma AK, Schneider KA, Anvikar AR, Bharti PK. Repurposing FDA-approved drugs to target malaria through inhibition of dihydrofolate reductase in the folate biosynthesis pathway: A prospective approach. J Cell Biochem. 2024 Mar;125(3). doi: 10.1002/jcb.30533. Epub 2024 Feb 12. PMID: 38345373.
• Verma, K., Lahariya, A. K., Dubey, S., Verma AK, Das, A., Schneider, K. A., & Bharti, P. K. (2021). An integrated virtual screening and drug repurposing strategy for the discovery of new antimalarial drugs against Plasmodium falciparum phosphatidylinositol 3-kinase. Journal of cellular biochemistry, 122(10), 1326–1336. (Impact factor: 3.5)
• Shrivastva, S., Chakma, T., Das, A., & Verma AK. (2021). Digitisation and realtime sharing of unified surveillance tool and clinicopathological data for efficient management of disease outbreaks. The International journal of health planning and management, 36(4), 1352–1354. (Impact factor: 1.45)
• Krishna, S., Mishra, S., Tiwari, P., Vishwakarma, A. K., Khandai, S., Shrivastava, S., Verma AK, Tiwari, S., Barman, H., Jhariya, S., Tiwari, P., Tidgam, A. S., Varun, B. M., Singh, S., Yerane, N., Tembhurne, C. R., Mandavi, P. L., Tekam, S. S., Malik, M., Behera, K. P., … Bharti, P. K. (2021). Therapeutic efficacy of artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in four malaria endemic states of India. Malaria journal, 20(1), 229. (Impact factor: 3.1)
• Krishna, S., Bhandari, S., Vishwakarma, A. K., Verma AK, Singh, M. P., Sharma, A., Singh, N., & Bharti, P. K. (2021). Genetic diversity and expression profile of Plasmodium falciparum Pf34 gene supports its immunogenicity. Current research in translational medicine, 69(4), 103308. (Impact factor: 4.5)
• Ahmad, A., Soni, P., Kumar, L., Singh, M. P., Verma AK, Sharma, A., Das, A., & Bharti, P. K. (2021). Comparison of polymerase chain reaction, microscopy, and rapid diagnostic test in malaria detection in a high burden state (Odisha) of India. Pathogens and global health, 115(4), 267–272. (Impact factor: 2.89)
• Bahadur T, Chaudhry R, Bamola VD, Chutani AM, Verma AK, Paul J. Analysis of gut bacterial community composition in obese and lean Indian participants by denaturing gradient gel electrophoresis. Indian J Health Sci Biomed Res 2021;14:42-7. (Impact factor: 0)
• Verma AK and Das A. The success of malaria digital dashboard is linked with development of basic health care infrastructure in rural/tribal areas (2021) BMJ Global Health. (Impact factor: 8)
• Shrivas, S., Patel, M., Kumar, R., Gwal, A., Uikey, R., Tiwari, S. K., Verma AK, Thota, P., Das, A., Bharti, P. K., & Shanmugam, R. (2021). Evaluation of Microchip-Based Point-Of-Care Device "Gazelle" for Diagnosis of Sickle Cell Disease in India. Frontiers in medicine, 8, 639208. (Impact factor: 5.0)
• Shrivastava S, Verma AK, Saha KB. South Africa’s Health: Traditional healers in South Africa: a parallel health care system connecting tribal healers to Primary Health Care: A purpose stride, but difficult to accomplish (Letter to editor). BMJ. Jan 2022. (Impact factor: 8)

• Nema S, Singh A, Krishna S, Poriya R, Dubey S, Ali NA, Singh MP, Verma AK, Das A, Bharti PK. Unreported mixed Plasmodium species infection may increase vivax malaria in India: a challenge for malaria elimination. Trans R Soc Trop Med Hyg. 2022 Jul 6;116(7):600-603. (Impact factor: 2.47)
• Verma K, Lahariya AK, Verma G, Kumari M, Gupta D, Maurya N, Verma AK, Mani A, Schneider KA, Bharti PK. Screening of potential antiplasmodial agents targeting cysteine protease-Falcipain 2: a computational pipeline. J Biomol Struct Dyn. 2022 Oct 11:1-44. (Impact factor: 3.4)
• Iyer LR, Chandel N, Verma AK, Thakur V, Paul J, Mandal AK, Bhattacharya A. Effect of Entamoeba histolytica infection on gut microbial diversity and composition in diarrheal patients from New Delhi. Parasitol Res. 2022 Nov 18. (Impact factor: 2.38)

• Ali NA, Nema S, Schneider KA, Krishna S, Verma AK, Das A, Bharti PK. Low prevalence of antimalarial-resistance mutations in India during 2014-15: Impact of combining first-line therapy with primaquine. J Infect Dis. 2023 Dec 2:jiad553. (Impact factor: 6.4)
• Verma K, Chaturvedi R, Lahariya AK, Verma AK, Schneider KA, Anvikar AR, Bharti PK. Repurposing FDA-approved drugs to target malaria through inhibition of dihydrofolate reductase in the folate biosynthesis pathway: A prospective approach. J Cell Biochem. 2024 Mar;125(3):e30533. (Impact factor: 4.4)